Gamer.Site Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Esperion Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Esperion_Therapeutics

    Esperion Therapeutics. Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

  3. Heart Disease Drugmaker Esperion Therapeutics Reports ... - AOL

    www.aol.com/finance/heart-disease-drugmaker...

    Tuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up 467% Y/Y, surpassing the consensus of $84.51 million. The company reported an EPS of $0.34, a ...

  4. Bempedoic acid - Wikipedia

    en.wikipedia.org/wiki/Bempedoic_acid

    Bempedoic acid. Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels). [2] [3] The most common side effects include hyperuricemia (high blood levels of uric acid), pain in arms or legs, and anemia (low red blood cell counts). [3]

  5. Cholesterol-lowering drug can help people who can't or won't ...

    www.aol.com/news/cholesterol-lowering-drug-help...

    Esperion, the company that makes and markets bempedoic acid, sells it alone or coupled with a second cholesterol-lowering medication, called ezetimibe. Both versions are priced at $395 per month ...

  6. Esperion Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update PLYMOUTH, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (NAS: ESPR) , a clinical-stage ...

  7. ApoA-I Milano - Wikipedia

    en.wikipedia.org/wiki/ApoA-I_Milano

    Esperion Therapeutics, a high tech venture capital start-up, demonstrated efficacy in both animals and humans, spending many millions of dollars over several years to conduct a single human trial which showed impressive and rapid efficacy by IVUS of coronary arteries. However, over the course of the project they produced only enough ApoA-I ...

  8. Esperion Therapeutics to Present at Stifel Nicolaus 2013 ...

    www.aol.com/news/2013-09-10-esperion...

    Esperion Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference PLYMOUTH, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (NAS: ESPR) , a clinical-stage biopharmaceutical ...

  9. Lovastatin - Wikipedia

    en.wikipedia.org/wiki/Lovastatin

    Lovastatin is a prodrug, an inactive lactone in its native form, the gamma-lactone closed ring form in which it is administered, is hydrolysed in vivo to the β-hydroxy acid open ring form; which is the active form. Lovastatin and other statins have been studied for their chemopreventive and chemotherapeutic effects.